All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F17%3A00475267" target="_blank" >RIV/61388963:_____/17:00475267 - isvavai.cz</a>

  • Result on the web

    <a href="https://aidsrestherapy.biomedcentral.com/articles/10.1186/s12981-017-0144-0" target="_blank" >https://aidsrestherapy.biomedcentral.com/articles/10.1186/s12981-017-0144-0</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s12981-017-0144-0" target="_blank" >10.1186/s12981-017-0144-0</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals

  • Original language description

    Progression rates from initial HIV-1 infection to advanced AIDS vary significantly among infected individuals. A distinct subgroup of HIV-1-infected individuals--termed viremic non-progressors (VNP) or controllers--do not seem to progress to AIDS, maintaining high CD4(+) T cell counts despite high levels of viremia for many years. Several studies have evaluated multiple host factors, including immune activation, trying to elucidate the atypical HIV-1 disease progression in these patients, however, limited work has been done to characterize viral factors in viremic controllers. We analyzed HIV-1 isolates from three VNP individuals and compared the replicative fitness, near full-length HIV-1 genomes and intra-patient HIV-1 genetic diversity with viruses from three typical (TP) and one rapid (RP) progressor individuals. Viremic non-progressors and typical patients were infected for > 10 years (range 10-17 years), with a mean CD4(+) T-cell count of 472 cells/mm(3) (442-529) and 400 cells/mm(3) (126-789), respectively. VNP individuals had a less marked decline in CD4(+) cells (mean -0.56, range -0.4 to -0.7 CD4(+)/month) than TP patients (mean -10.3, -8.2 to -13.1 CD4(+)/month). Interestingly, VNP individuals carried viruses with impaired replicative fitness, compared to HIV-1 isolates from the TP and RP patients (p < 0.05, 95% CI). Although analyses of the near full-length HIV-1 genomes showed no clear patterns of single-nucleotide polymorphisms (SNP) that could explain the decrease in replicative fitness, both the number of SNPs and HIV-1 population diversity correlated inversely with the replication capacity of the viruses (r = -0.956 and r = -0.878, p < 0.01, respectively). It is likely that complex multifactorial parameters govern HIV-1 disease progression in each individual, starting with the infecting virus (phenotype, load, and quasispecies diversity) and the intrinsic ability of the host to respond to the infection. Here we analyzed a subset of viremic controller patients and demonstrated that similar to the phenomenon observed in patients with a discordant response to antiretroviral therapy (i.e., high CD4(+) cell counts with detectable plasma HIV-1 RNA load), reduced viral replicative fitness seems to be linked to slow disease progression in these antiretroviral-naive individuals.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10607 - Virology

Result continuities

  • Project

    <a href="/en/project/LK11207" target="_blank" >LK11207: The Role of HIV Fitness on Disease Progression in the Absence of Antiretroviral Treatment</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    AIDS Research and Therapy

  • ISSN

    1742-6405

  • e-ISSN

  • Volume of the periodical

    14

  • Issue of the periodical within the volume

    Mar 20

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    17

  • Pages from-to

  • UT code for WoS article

    000397757000001

  • EID of the result in the Scopus database

    2-s2.0-85015618746